1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. |
---|
4 | 4 | | [Brackets] indicate matter deleted from existing law. |
---|
5 | 5 | | *hb1462* |
---|
6 | 6 | | |
---|
7 | 7 | | HOUSE BILL 1462 |
---|
8 | 8 | | J1 2lr3166 |
---|
9 | 9 | | |
---|
10 | 10 | | By: Delegate Cox |
---|
11 | 11 | | Introduced and read first time: February 25, 2022 |
---|
12 | 12 | | Assigned to: Rules and Executive Nominations |
---|
13 | 13 | | |
---|
14 | 14 | | A BILL ENTITLED |
---|
15 | 15 | | |
---|
16 | 16 | | AN ACT concerning 1 |
---|
17 | 17 | | |
---|
18 | 18 | | Health – Ivermectin – Standing Order 2 |
---|
19 | 19 | | (Protocol Drug Act) 3 |
---|
20 | 20 | | |
---|
21 | 21 | | FOR the purpose of authorizing licensed physicians and advanced practice registered 4 |
---|
22 | 22 | | nurses to prescribe ivermectin by issuing a standing order; establishing procedures 5 |
---|
23 | 23 | | for pharmacists to follow when issuing ivermectin under a standing order; and 6 |
---|
24 | 24 | | generally relating to a standing order for ivermectin. 7 |
---|
25 | 25 | | |
---|
26 | 26 | | BY adding to 8 |
---|
27 | 27 | | Article – Health – General 9 |
---|
28 | 28 | | Section 20–2201 and 20–2202 to be under the new subtitle “Subtitle 22. Ivermectin 10 |
---|
29 | 29 | | Standing Order” 11 |
---|
30 | 30 | | Annotated Code of Maryland 12 |
---|
31 | 31 | | (2019 Replacement Volume and 2021 Supplement) 13 |
---|
32 | 32 | | |
---|
33 | 33 | | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 14 |
---|
34 | 34 | | That the Laws of Maryland read as follows: 15 |
---|
35 | 35 | | |
---|
36 | 36 | | Article – Health – General 16 |
---|
37 | 37 | | |
---|
38 | 38 | | SUBTITLE 22. IVERMECTIN STANDING ORDER. 17 |
---|
39 | 39 | | |
---|
40 | 40 | | 20–2201. 18 |
---|
41 | 41 | | |
---|
42 | 42 | | IN THIS SUBTITLE, “STANDING ORDER ” MEANS A WRITTEN AND SIGNED 19 |
---|
43 | 43 | | PROTOCOL AUTHORED BY ONE OR MORE PHYSICIA NS OR ADVANCED PRACTICE 20 |
---|
44 | 44 | | REGISTERED NURSES LI CENSED UNDER THE HEALTH OCCUPATIONS ARTICLE. 21 |
---|
45 | 45 | | |
---|
46 | 46 | | 20–2202. 22 |
---|
47 | 47 | | 2 HOUSE BILL 1462 |
---|
48 | 48 | | |
---|
49 | 49 | | |
---|
50 | 50 | | (A) A LICENSED PHYSICIAN O R AN ADVANCED PRACTI CE REGISTERED 1 |
---|
51 | 51 | | NURSE WITH PRESCRIBI NG AUTHORITY MAY PRE SCRIBE IVERMECTIN BY ISSUING A 2 |
---|
52 | 52 | | STANDING ORDER . 3 |
---|
53 | 53 | | |
---|
54 | 54 | | (B) A STANDING ORDER ISSUE D UNDER SUBSECTION (A) OF THIS SECTION 4 |
---|
55 | 55 | | SHALL: 5 |
---|
56 | 56 | | |
---|
57 | 57 | | (1) SPECIFY A PROTOCOL TH AT ALLOWS PHARMACISTS LICENSED 6 |
---|
58 | 58 | | UNDER THE HEALTH OCCUPATIONS ARTICLE TO DISPENSE IVERMECTIN; 7 |
---|
59 | 59 | | |
---|
60 | 60 | | (2) SPECIFY A MECHANISM T O DOCUMENT SCREENING PERFORMED 8 |
---|
61 | 61 | | OF THE PATIENT AND THE PRESCRIPTION IN THE PATIENT’S MEDICAL RECORD ; AND 9 |
---|
62 | 62 | | |
---|
63 | 63 | | (3) INCLUDE A PLAN FOR EV ALUATING AND TREATIN G ADVERSE 10 |
---|
64 | 64 | | EVENTS. 11 |
---|
65 | 65 | | |
---|
66 | 66 | | (C) A PRESCRIPTION S WRITTEN UNDER THIS SECTION S HALL BE REGARDED 12 |
---|
67 | 67 | | AS BEING WRITTEN FOR A LEGITIMATE MED ICAL PURPOSE IN THE USUAL COURSE 13 |
---|
68 | 68 | | OF PROFESSIONAL PRAC TICE. 14 |
---|
69 | 69 | | |
---|
70 | 70 | | (D) A PHARMACIST LICENSED UNDER THE HEALTH OCCUPATIONS ARTICLE 15 |
---|
71 | 71 | | FOLLOWING A STANDING ORDER ISS UED UNDER THIS SECTI ON MAY DISPENSE 16 |
---|
72 | 72 | | IVERMECTIN TO INDIVI DUALS IN THE STATE WITHOUT A PRIOR PRESCRIPTION . 17 |
---|
73 | 73 | | |
---|
74 | 74 | | (E) A PHARMACIST , A PHARMACY, A PHYSICIAN, OR AN ADVANCED 18 |
---|
75 | 75 | | PRACTICE REGISTERED NURSE ISSUING OR FOL LOWING A STANDING OR DER ISSUED 19 |
---|
76 | 76 | | UNDER THIS SECTION M AY NOT SEEK A RELATED PERSONAL FINANCIAL B ENEFIT BY: 20 |
---|
77 | 77 | | |
---|
78 | 78 | | (1) PARTICIPATING IN ANY INCENTIVE–BASED PROGRAM ; OR 21 |
---|
79 | 79 | | |
---|
80 | 80 | | (2) ACCEPTING A NY INDUCEMENT THAT I NFLUENCES OR 22 |
---|
81 | 81 | | ENCOURAGES THERAPEUT IC OR PRODUCT CHANGES O R THE ORDERING OF TE STS 23 |
---|
82 | 82 | | OR SERVICES. 24 |
---|
83 | 83 | | |
---|
84 | 84 | | (F) (1) A PHARMACIST SHALL PRO VIDE EACH INDIVIDUAL WHO IS 25 |
---|
85 | 85 | | DISPENSED IVERMECTIN UNDER THI S SECTION WITH A STA NDARDIZED 26 |
---|
86 | 86 | | INFORMATION SHEET WR ITTEN IN PLAIN LANGUAGE. 27 |
---|
87 | 87 | | |
---|
88 | 88 | | (2) THE STANDARDIZED INFO RMATION SHEET SHALL INCLUDE THE 28 |
---|
89 | 89 | | IMPORTANCE OF FOLLOW –UP CARE AND HEALTH C ARE REFERRAL INFORMA TION. 29 |
---|
90 | 90 | | |
---|
91 | 91 | | (3) THE INFORMATION SHEET MAY NOT DISCOURAGE THE RECIP IENT 30 |
---|
92 | 92 | | FROM USING IVERMECTI N FOR THE TREATMENT OF COVID–19. 31 HOUSE BILL 1462 3 |
---|
93 | 93 | | |
---|
94 | 94 | | |
---|
95 | 95 | | |
---|
96 | 96 | | (G) (1) THE STATE BOARD OF PHYSICIANS MAY NOT DE NY, REVOKE, OR 1 |
---|
97 | 97 | | SUSPEND THE LICENSE OF OR OTHERWISE TAKE DI SCIPLINARY ACTION AG AINST A 2 |
---|
98 | 98 | | PHYSICIAN BASED ON A PHARMACIST ’S FAILURE TO FOLLOW A STANDING ORDER 3 |
---|
99 | 99 | | ISSUED UNDER THIS SE CTION IF THE REQUIREMENTS OF THIS SECTION ARE 4 |
---|
100 | 100 | | SATISFIED BY THE PHY SICIAN. 5 |
---|
101 | 101 | | |
---|
102 | 102 | | (2) THE STATE BOARD OF NURSING MAY NOT DENY , REVOKE, OR 6 |
---|
103 | 103 | | SUSPEND THE LICENSE OF OR OTHERWISE TAKE DI SCIPLINARY ACTION AG AINST AN 7 |
---|
104 | 104 | | ADVANCED PRACTICE REGIS TERED NURSE BASED ON A PHARMACIST ’S FAILURE TO 8 |
---|
105 | 105 | | FOLLOW A STANDING OR DER ISSUED UNDER THI S SECTION IF THE REQUIREMENTS 9 |
---|
106 | 106 | | OF THIS SECTION ARE SATISFIED BY THE ADVANCED PRACTICE RE GISTERED NURSE . 10 |
---|
107 | 107 | | |
---|
108 | 108 | | (3) THE STATE BOARD OF PHARMACY MAY NOT DEN Y, REVOKE, OR 11 |
---|
109 | 109 | | SUSPEND THE LICENSE OF OR OTHERWISE TAKE DI SCIPLINARY AGAINST A 12 |
---|
110 | 110 | | PHARMACIST WHO FOLLO WS A STANDING ORDER ISSUED UNDER THIS SE CTION 13 |
---|
111 | 111 | | BASED ON A DEFECT IN THE STANDING ORDER I F THE REQUIREMENTS OF THIS 14 |
---|
112 | 112 | | SECTION ARE OTHERWISE SATISF IED BY THE PHARMACIS T. 15 |
---|
113 | 113 | | |
---|
114 | 114 | | (H) THE DEPARTMENT MAY ADOPT REGULATIONS TO CARRY OUT THIS 16 |
---|
115 | 115 | | SECTION. 17 |
---|
116 | 116 | | |
---|
117 | 117 | | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 18 |
---|
118 | 118 | | October 1, 2022. 19 |
---|